These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34570118)

  • 1. [Pulmonary arterial hypertension or heart failure with preserved ejection fraction? Beyond heart catheterization: a roadmap for challenging cases].
    D'Alto M; Romeo E; Argiento P; Blasi E; Di Vilio A; Golino P
    G Ital Cardiol (Rome); 2021 Oct; 22(10):844-850. PubMed ID: 34570118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fluid Challenge Test for the Diagnosis of Occult Heart Failure.
    D'Alto M; Badesch D; Bossone E; Borlaug BA; Brittain E; Humbert M; Naeije R
    Chest; 2021 Feb; 159(2):791-797. PubMed ID: 32805242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.
    Hummel YM; Liu LCY; Lam CSP; Fonseca-Munoz DF; Damman K; Rienstra M; van der Meer P; Rosenkranz S; van Veldhuisen DJ; Voors AA; Hoendermis ES
    Eur J Heart Fail; 2017 Dec; 19(12):1651-1660. PubMed ID: 28984057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab].
    Caravita S; Picariello C; Garascia A; Misuraca L; De Tommasi E; Imbalzano E; Enea I; Roncon L; Vatrano M;
    G Ital Cardiol (Rome); 2022 Jul; 23(7):533-541. PubMed ID: 35771019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-induced changes in pulmonary artery wedge pressure in adults post-Fontan versus heart failure with preserved ejection fraction and non-cardiac dyspnoea.
    Miranda WR; Borlaug BA; Jain CC; Anderson JH; Hagler DJ; Connolly HM; Egbe AC
    Eur J Heart Fail; 2023 Jan; 25(1):17-25. PubMed ID: 36194660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Combined Post- and Precapillay Pulmonary Hypertension.
    Huis In't Veld AE; Oosterveer FPT; De Man FS; Marcus JT; Nossent EJ; Boonstra A; Van Rossum ACB; Vonk Noordegraaf A; Bogaard HJ; Handoko ML
    J Card Fail; 2020 Jan; 26(1):26-34. PubMed ID: 31394199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction.
    Baratto C; Caravita S; Soranna D; Faini A; Dewachter C; Zambon A; Perego GB; Bondue A; Senni M; Badano LP; Parati G; Vachiéry JL
    Circ Heart Fail; 2021 May; 14(5):e007555. PubMed ID: 33951935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Simple Derived Prediction Score for the Identification of an Elevated Pulmonary Artery Wedge Pressure Using Precatheterization Clinical Data in Patients Referred to a Pulmonary Hypertension Center.
    Richter SE; Roberts KE; Preston IR; Hill NS
    Chest; 2016 May; 149(5):1261-8. PubMed ID: 26501213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction.
    van de Bovenkamp AA; Wijkstra N; Oosterveer FPT; Vonk Noordegraaf A; Bogaard HJ; van Rossum AC; de Man FS; Borlaug BA; Handoko ML
    Circ Heart Fail; 2022 Apr; 15(4):e008935. PubMed ID: 35311526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.
    Andersen MJ; Olson TP; Melenovsky V; Kane GC; Borlaug BA
    Circ Heart Fail; 2015 Jan; 8(1):41-8. PubMed ID: 25342738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension.
    Maor E; Grossman Y; Balmor RG; Segel M; Fefer P; Ben-Zekry S; Buber J; DiSegni E; Guetta V; Ben-Dov I; Segev A
    Eur J Heart Fail; 2015 Feb; 17(2):151-8. PubMed ID: 25488133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension.
    Fox BD; Shimony A; Langleben D; Hirsch A; Rudski L; Schlesinger R; Eisenberg MJ; Joyal D; Hudson M; Boutet K; Serban A; Masetto A; Baron M
    Eur Respir J; 2013 Oct; 42(4):1083-91. PubMed ID: 23258775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Ahmed S; Ahmed A; Rådegran G
    Int J Cardiol; 2021 Dec; 345():68-76. PubMed ID: 34710494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Baratto C; Caravita S; Soranna D; Dewachter C; Bondue A; Zambon A; Badano LP; Parati G; Vachiéry JL
    ESC Heart Fail; 2022 Oct; 9(5):3079-3091. PubMed ID: 35748109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea.
    Omote K; Verbrugge FH; Sorimachi H; Omar M; Popovic D; Obokata M; Reddy YNV; Borlaug BA
    Eur J Heart Fail; 2023 Feb; 25(2):185-196. PubMed ID: 36420788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.
    Olsson KM; Sommer L; Fuge J; Welte T; Hoeper MM
    Respir Res; 2015 Mar; 16(1):34. PubMed ID: 25853979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
    van Empel VP; Mariani J; Borlaug BA; Kaye DM
    J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.